>
Imricor Medical Systems Inc logo

IMR - Imricor Medical Systems Inc Share Price

A$1.95 -0.0  -0.8%

Last Trade - 4:48am

Sector
Healthcare
Size
Small Cap
Market Cap £136.5m
Enterprise Value £119.5m
Revenue £497k
Position in Universe 575th / 1911
Bullish
Bearish
Unlock IMR Revenue
Momentum
Relative Strength (%)
1m -8.89%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -33.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.52 0.43 1.00 0.64 0.70 6.22 27.2 +7.6%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, ImricorMedical Systems Inc revenues increased 10% to $702K. Netloss decreased 6% to $12.4M. Revenues reflect Productrevenues increase of 24% to $468K. Lower net loss reflectsBeneficial conversion feature expense decrease from $4.1M(expense) to $0K, Down round expense decrease from $1.8M(expense) to $0K, Interest expense decrease of 71% to $301K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IMR Revenue Unlock IMR Revenue

Net Income

IMR Net Income Unlock IMR Revenue

Normalised EPS

IMR Normalised EPS Unlock IMR Revenue

PE Ratio Range

IMR PE Ratio Range Unlock IMR Revenue

Dividend Yield Range

IMR Dividend Yield Range Unlock IMR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
IMR EPS Forecasts Unlock IMR Revenue
Profile Summary

Imricor Medical Systems, Inc. is a United States-based medical device company. The Company is focused on designing, manufacturing and selling magnetic resonance imaging (MRI)-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include the Advantage- mitral regurgitation (MR) electrophysiology (EP) Recorder/Stimulator System, the Vision-MR Ablation Catheter and the Vision-MR Dispersive Electrode. Its Advantage-MR EP Recorder/Stimulator is an electrophysiology amplifier and recording system with integrated cardiac stimulator. Vision-MR Ablation Catheter is an irrigated tip, single-use radiofrequency (RF) ablation catheter. Vision-MR Dispersive Electrode is a dispersive electrode. The Advantage-MR EP Recorder/Stimulator System is capital equipment which can be used in multiple procedures.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated May 22, 2006
Public Since August 30, 2019
No. of Shareholders: 871
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P/ASX All Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 125,549,550
Free Float (0.0%)
Eligible for
ISAs
SIPPs
IMR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IMR
Upcoming Events for IMR
Thursday 13th May, 2021 Estimate
Imricor Medical Systems Inc Annual Shareholders Meeting
Frequently Asked Questions for Imricor Medical Systems Inc
What is the Imricor Medical Systems Inc share price?

As of 4:48am, shares in Imricor Medical Systems Inc are trading at A$1.95, giving the company a market capitalisation of £136.5m. This share price information is delayed by 15 minutes.

How has the Imricor Medical Systems Inc share price performed this year?

Shares in Imricor Medical Systems Inc are currently trading at A$1.95 and the price has moved by 41.52% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Imricor Medical Systems Inc price has moved by 7.3% over the past year.

What are the analyst and broker recommendations for Imricor Medical Systems Inc?

There are no analysts currently covering Imricor Medical Systems Inc.

When will Imricor Medical Systems Inc next release its financial results?

Imricor Medical Systems Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Imricor Medical Systems Inc dividend yield?

Imricor Medical Systems Inc does not currently pay a dividend.

Does Imricor Medical Systems Inc pay a dividend?

Imricor Medical Systems Inc does not currently pay a dividend.

When does Imricor Medical Systems Inc next pay dividends?

Imricor Medical Systems Inc does not currently pay a dividend.

How do I buy Imricor Medical Systems Inc shares?

To buy shares in Imricor Medical Systems Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Imricor Medical Systems Inc?

Shares in Imricor Medical Systems Inc are currently trading at A$1.95, giving the company a market capitalisation of £136.5m.

Where are Imricor Medical Systems Inc shares listed? Where are Imricor Medical Systems Inc shares listed?

Here are the trading details for Imricor Medical Systems Inc:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: IMR
What kind of share is Imricor Medical Systems Inc?

Based on an overall assessment of its quality, value and momentum, Imricor Medical Systems Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Imricor Medical Systems Inc share price forecast 2021?

Shares in Imricor Medical Systems Inc are currently priced at A$1.95. At that level they are trading at 60.03% discount to the analyst consensus target price of 0.00.

Analysts covering Imricor Medical Systems Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.1419230565 for the next financial year.

How can I tell whether the Imricor Medical Systems Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Imricor Medical Systems Inc. Over the past six months, the relative strength of its shares against the market has been -32.2%. At the current price of A$1.95, shares in Imricor Medical Systems Inc are trading at -11.2% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Imricor Medical Systems Inc PE Ratio?

We were not able to find PE ratio data for Imricor Medical Systems Inc.

Who are the key directors of Imricor Medical Systems Inc?

We were unable to find the directors for Imricor Medical Systems Inc.

Who are the major shareholders of Imricor Medical Systems Inc?

Here are the top five shareholders of Imricor Medical Systems Inc based on the size of their shareholding:

Siemens Medical Solutions USA, Inc. Corporation
Percentage owned: 7.26% (8.38m shares)
BlackRock Investment Management (Australia) Ltd. Investment Advisor
Percentage owned: 6.8% (7.85m shares)
Herreid (Warren G II) Individual Investor
Percentage owned: 6.65% (7.68m shares)
Regal Funds Management Pty. Ltd. Hedge Fund
Percentage owned: 4.87% (5.63m shares)
Tibbles (Mark) Individual Investor
Percentage owned: 3.97% (4.58m shares)
Similar to IMR
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.